ANDA 78767, held by Hikma Pharms. Levofloxacin.
As of Nov 16, 2026, ANDA 78767 (Levofloxacin), held by Hikma Pharms, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 31, 2011 | Original application | Tentative approval | None posted |
| Levofloxacin250MG · tablet; oral | Levofloxacin | None (tentative approval) |
| Levofloxacin500MG · tablet; oral | Levofloxacin | None (tentative approval) |
| Levofloxacin750MG · tablet; oral | Levofloxacin | None (tentative approval) |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters